References
- Sharma L, Losier A, Tolbert T, Dela Cruz CS, Marion CR. Atypical pneumonia: updates on Legionella, Chlamydophila, and Mycoplasma pneumonia. Clin Chest Med 2017;38:45-58. https://doi.org/10.1016/j.ccm.2016.11.011
- Yu Y, Fei A. Atypical pathogen infection in community-acquired pneumonia. Biosci Trends 2016;10:7-13. https://doi.org/10.5582/bst.2016.01021
- Basarab M, Macrae MB, Curtis CM. Atypical pneumonia. Curr Opin Pulm Med 2014;20:247-51. https://doi.org/10.1097/MCP.0000000000000048
- Don M, Canciani M, Korppi M. Community-acquired pneumonia in children: what's old? What's new? Acta Paediatr 2010;99:1602-8. https://doi.org/10.1111/j.1651-2227.2010.01924.x
- Hammerschlag MR. Pneumonia due to Chlamydia pneumoniae in children: epidemiology, diagnosis, and treatment. Pediatr Pulmonol 2003; 36:384-90. https://doi.org/10.1002/ppul.10326
- Phares CR, Wangroongsarb P, Chantra S, Paveenkitiporn W, Tondella ML, Benson RF, et al. Epidemiology of severe pneumonia caused by Legionella longbeachae, Mycoplasma pneumoniae, and Chlamydia pneumoniae: 1-year, population-based surveillance for severe pneumonia in Thailand. Clin Infect Dis 2007;45:e147-55. https://doi.org/10.1086/523003
- Yang HJ, Song DJ, Shim JY. Mechanism of resistance acquisition and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Korean J Pediatr 2017;60:167-74. https://doi.org/10.3345/kjp.2017.60.6.167
- Tanaka T, Oishi T, Miyata I, Wakabayashi S, Kono M, Ono S, et al. Macrolide-resistant Mycoplasma pneumoniae infection, Japan, 2008-2015. Emerg Infect Dis 2017;23:1703-6. https://doi.org/10.3201/eid2310.170106
- Shadoud L, Almahmoud I, Jarraud S, Etienne J, Larrat S, Schwebel C, et al. Hidden selection of bacterial resistance to fluoroquinolones in vivo: the case of Legionella pneumophila and humans. EBioMedicine 2015;2: 1179-85. https://doi.org/10.1016/j.ebiom.2015.07.018
- Korea Centers for Disease Control and Prevention (KCDC). 2017 Guidelines for the antibiotic use in children with lower respiratory tract infections [Internet]. Cheongju (Korea): KCDC; 2017 [cited 2019 Mar 5]. Available from: https://www.cdc.go.kr/board.es?mid=a20507020000&bid=0019&tag=&act=view&list_no=138090.
- Izumikawa K. Clinical features of severe or fatal Mycoplasma pneumoniae pneumonia. Front Microbiol 2016;7:800. https://doi.org/10.3389/fmicb.2016.00800
- Korea Centers for Disease Control and Prevention (KCDC). Infectious disease portal. Infectious disease surveillance yearbook 2017 [Internet]. Cheongju (Korea): KCDC; 2017 [cited 2019 Mar 5]. Available from: http://www.cdc.go.kr/npt/biz/npp/portal/nppPblctDtaMain.do.
- Matsubara K, Morozumi M, Okada T, Matsushima T, Komiyama O, Shoji M, et al. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients. J Infect Chemother 2009;15:380-3. https://doi.org/10.1007/s10156-009-0715-7
- Shen Y, Zhang J, Hu Y, Shen K. Combination therapy with immunemodulators and moxifloxacin on fulminant macrolide-resistant Mycoplasma pneumoniae infection: a case report. Pediatr Pulmonol 2013;48:519-22. https://doi.org/10.1002/ppul.22650
- Luo Z, Luo J, Liu E, Xu X, Liu Y, Zeng F, et al. Effects of prednisolone on refractory mycoplasma pneumoniae pneumonia in children. Pediatr Pulmonol 2014;49:377-80. https://doi.org/10.1002/ppul.22752
- Yiallouros PK, Papadouri T, Karaoli C, Papamichael E, Zeniou M, Pieridou-Bagatzouni D, et al. First outbreak of nosocomial Legionella infection in term neonates caused by a cold mist ultrasonic humidifier. Clin Infect Dis 2013;57:48-56. https://doi.org/10.1093/cid/cit176
- Jain S, Self WH, Wunderink RG; CDC EPIC Study Team. Communityacquired pneumonia requiring hospitalization. N Engl J Med 2015;373:2382.
- Sohn JW, Park SC, Choi YH, Woo HJ, Cho YK, Lee JS, et al. Atypical pathogens as etiologic agents in hospitalized patients with community-acquired pneumonia in Korea: a prospective multi-center study. J Korean Med Sci 2006;21:602-7. https://doi.org/10.3346/jkms.2006.21.4.602
- Hammerschlag MR. Chlamydia trachomatis and Chlamydia pneumoniae infections in children and adolescents. Pediatr Rev 2004;25:43-51. https://doi.org/10.1542/pir.25-2-43
- Meyer Sauteur PM, Unger WW, Nadal D, Berger C, Vink C, van Rossum AM. Infection with and carriage of Mycoplasma pneumoniae in children. Front Microbiol 2016;7:329. https://doi.org/10.3389/fmicb.2016.00329
- Hickman-Davis JM, McNicholas-Bevensee C, Davis IC, Ma HP, Davis GC, Bosworth CA, et al. Reactive species mediate inhibition of alveolar type II sodium transport during mycoplasma infection. Am J Respir Crit Care Med 2006;173:334-44. https://doi.org/10.1164/rccm.200501-155OC
- Saraya T, Nakata K, Nakagaki K, Motoi N, Iihara K, Fujioka Y, et al. Identification of a mechanism for lung inflammation caused by Mycoplasma pneumoniae using a novel mouse model. Results Immunol 2011; 1:76-87. https://doi.org/10.1016/j.rinim.2011.11.001
- Shimizu T, Kida Y, Kuwano K. A dipalmitoylated lipoprotein from Mycoplasma pneumoniae activates NF-kappa B through TLR1, TLR2, and TLR6. J Immunol 2005;175:4641-6. https://doi.org/10.4049/jimmunol.175.7.4641
- Yang J, Hooper WC, Phillips DJ, Talkington DF. Cytokines in Mycoplasma pneumoniae infections. Cytokine Growth Factor Rev 2004;15:157-68. https://doi.org/10.1016/j.cytogfr.2004.01.001
- Becker A, Kannan TR, Taylor AB, Pakhomova ON, Zhang Y, Somarajan SR, et al. Structure of CARDS toxin, a unique ADP-ribosylating and vacuolating cytotoxin from Mycoplasma pneumoniae. Proc Natl Acad Sci U S A 2015;112:5165-70. https://doi.org/10.1073/pnas.1420308112
- Baroja-Mazo A, Martin-Sanchez F, Gomez AI, Martinez CM, Amores-Iniesta J, Compan V, et al. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nat Immunol 2014;15:738-48. https://doi.org/10.1038/ni.2919
- Medina JL, Coalson JJ, Brooks EG, Le Saux CJ, Winter VT, Chaparro A, et al. Mycoplasma pneumoniae CARDS toxin exacerbates ovalbumin-induced asthma-like inflammation in BALB/c mice. PLoS One 2014;9:e102613. https://doi.org/10.1371/journal.pone.0102613
- Lee KY. Pneumonia, acute respiratory distress syndrome, and early immune-modulator therapy. Int J Mol Sci 2017;18:388. https://doi.org/10.3390/ijms18020388
- Saraya T, Kurai D, Nakagaki K, Sasaki Y, Niwa S, Tsukagoshi H, et al. Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications. Front Microbiol 2014;5:410.
- Yang EA, Kang HM, Rhim JW, Kang JH, Lee KY. Early corticosteroid therapy for Mycoplasma pneumoniae pneumonia irrespective of used antibiotics in children. J Clin Med 2019;8:726. https://doi.org/10.3390/jcm8050726
- Chen CJ, Juan CJ, Hsu ML, Lai YS, Lin SP, Cheng SN. Mycoplasma pneumoniae infection presenting as neutropenia, thrombocytopenia, and acute hepatitis in a child. J Microbiol Immunol Infect 2004;37:128-30.
- Fernald GW. Immunologic mechanisms suggested in the association of M. pneumoniae infection and extrapulmonary disease: a review. Yale J Biol Med 1983;56:475-9.
- Bastidas RJ, Elwell CA, Engel JN, Valdivia RH. Chlamydial intracellular survival strategies. Cold Spring Harb Perspect Med 2013;3:a010256.
- Gotoh K, Nishimura N, Ohshima Y, Arakawa Y, Hosono H, Yamamoto Y, et al. Detection of Mycoplasma pneumoniae by loop-mediated isothermal amplification (LAMP) assay and serology in pediatric community-acquired pneumonia. J Infect Chemother 2012;18:662-7. https://doi.org/10.1007/s10156-012-0388-5
- Chen H, Weng H, Lin M, He P, Li Y, Xie Q, et al. The clinical significance of FilmArray respiratory panel in diagnosing community-acquired pneumonia. Biomed Res Int 2017;2017:7320859.
- Ou L, Lv Q, Wu C, Hao H, Zheng Y, Jiang Y. Development of a lateral flow immunochromatographic assay for rapid detection of Mycoplasma pneumoniae-specific IgM in human serum specimens. J Microbiol Methods 2016;124:35-40. https://doi.org/10.1016/j.mimet.2016.03.006
- Medjo B, Atanaskovic-Markovic M, Radic S, Nikolic D, Lukac M, Djukic S. Mycoplasma pneumoniae as a causative agent of community-acquired pneumonia in children: clinical features and laboratory diagnosis. Ital J Pediatr 2014;40:104. https://doi.org/10.1186/s13052-014-0104-4
- Yoo SJ, Oh HJ, Shin BM. Evaluation of four commercial IgG- and IgM-specific enzyme immunoassays for detecting Mycoplasma pneumoniae antibody: comparison with particle agglutination assay. J Korean Med Sci 2007;22:795-801. https://doi.org/10.3346/jkms.2007.22.5.795
- Lee SC, Youn YS, Rhim JW, Kang JH, Lee KY. Early serologic diagnosis of Mycoplasma pneumoniae pneumonia: an observational study on changes in titers of specific-IgM antibodies and cold agglutinins. Medicine (Baltimore) 2016;95:e3605. https://doi.org/10.1097/md.0000000000003605
- Chang HY, Chang LY, Shao PL, Lee PI, Chen JM, Lee CY, et al. Comparison of real-time polymerase chain reaction and serological tests for the confirmation of Mycoplasma pneumoniae infection in children with clinical diagnosis of atypical pneumonia. J Microbiol Immunol Infect 2014;47:137-44. https://doi.org/10.1016/j.jmii.2013.03.015
- Spuesens EB, Fraaij PL, Visser EG, Hoogenboezem T, Hop WC, van Adrichem LN, et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med 2013;10:e1001444. https://doi.org/10.1371/journal.pmed.1001444
- Beraud L, Gervasoni K, Freydiere AM, Descours G, Ranc AG, Vandenesch F, et al. Comparison of Sofia Legionella FIA and BinaxNOW® Legionella urinary antigen card in two national reference centers. Eur J Clin Microbiol Infect Dis 2015;34:1803-7. https://doi.org/10.1007/s10096-015-2415-9
- Lee SJ, Jung HH, Kim SK, Choi DH, Han SS, Nam EC, et al. The first isolation of Chlamydia pneumoniae from a Korean patient. Tuberc Respir Dis 2002;53:569-76. https://doi.org/10.4046/trd.2002.53.5.569
- Miyashita N, Kawai Y, Tanaka T, Akaike H, Teranishi H, Wakabayashi T, et al. Antibody responses of Chlamydophila pneumoniae pneumonia: why is the diagnosis of C. pneumoniae pneumonia difficult? J Infect Chemother 2015;21:497-501. https://doi.org/10.1016/j.jiac.2015.03.003
- Dowell SF, Peeling RW, Boman J, Carlone GM, Fields BS, Guarner J, et al. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 2001;33:492-503. https://doi.org/10.1086/322632
- Pierce VM, Elkan M, Leet M, McGowan KL, Hodinka RL. Comparison of the Idaho Technology FilmArray system to real-time PCR for detection of respiratory pathogens in children. J Clin Microbiol 2012;50:364-71. https://doi.org/10.1128/JCM.05996-11
- Li YN, Liu L, Qiao HM, Cheng H, Cheng HJ. Post-infectious bronchiolitis obliterans in children: a review of 42 cases. BMC Pediatr 2014;14:238. https://doi.org/10.1186/1471-2431-14-238
- Sung JJ, Kim EJ, Sun YH, Jeon IS, Tchah H, Ryoo E, et al. Clinical presentations of Chlamydia pneumoniae in children hospitalized for acute respiratory infections: a comparison to Mycoplasma pneumonia. Allergy Asthma Respir Dis 2015;3:346-51. https://doi.org/10.4168/aard.2015.3.5.346
- Smith CB, Friedewald WT, Chanock RM. Shedding of Mycoplasma pneumoniae after tetracycline and erythromycin therapy. N Engl J Med 1967;276:1172-5. https://doi.org/10.1056/NEJM196705252762103
- Germanakis I, Galanakis E, Parthenakis F, Vardas PE, Kalmanti M. Clarithromycin treatment and QT prolongation in childhood. Acta Paediatr 2006;95:1694-6. https://doi.org/10.1080/08035250600764800
- Sanchez AR, Rogers RS 3rd, Sheridan PJ. Tetracycline and other tetracycline-derivative staining of the teeth and oral cavity. Int J Dermatol 2004; 43:709-15. https://doi.org/10.1111/j.1365-4632.2004.02108.x
- McKenna BE, Lamey PJ, Kennedy JG, Bateson J. Minocycline-induced staining of the adult permanent dentition: a review of the literature and report of a case. Dent Update 1999;26:160-2. https://doi.org/10.12968/denu.1999.26.4.160
- Szarfman A, Chen M, Blum MD. More on fluoroquinolone antibiotics and tendon rupture. N Engl J Med 1995;332:193. https://doi.org/10.1056/NEJM199501193320319
- Rosanova MT, Lede R, Capurro H, Petrungaro V, Copertari P. Assessing fluoroquinolones as risk factor for musculoskeletal disorders in children: a systematic review and meta-analysis. Arch Argent Pediatr 2010;108:524-31. https://doi.org/10.1590/S0325-00752010000600008
- Forsythe CT, Ernst ME. Do fluoroquinolones commonly cause arthropathy in children? CJEM 2007;9:459-62. https://doi.org/10.1017/s1481803500015517
- Jackson MA, Schutze GE; Committee on Infectious Diseases. The use of systemic and topical fluoroquinolones. Pediatrics 2016;138:e20162706. https://doi.org/10.1542/peds.2016-2706
- Yamazaki T, Kenri T. Epidemiology of Mycoplasma pneumoniae infections in Japan and therapeutic strategies for macrolide-resistant M. pneumoniae. Front Microbiol 2016;7:693. https://doi.org/10.3389/fmicb.2016.00693
- Okubo Y, Michihata N, Morisaki N, Uda K, Miyairi I, Ogawa Y, et al. Recent trends in practice patterns and impact of corticosteroid use on pediatric Mycoplasma pneumoniae-related respiratory infections. Respir Investig 2018;56:158-65. https://doi.org/10.1016/j.resinv.2017.11.005
- Deguchi T, Ito S, Yasuda M, Sato Y, Uchida C, Sawamura M, et al. Surveillance of the prevalence of macrolide and/or fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Japan. J Infect Chemother 2018;24:861-7. https://doi.org/10.1016/j.jiac.2018.08.009
- Tamura A, Matsubara K, Tanaka T, Nigami H, Yura K, Fukaya T. Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children. J Infect 2008;57:223-8. https://doi.org/10.1016/j.jinf.2008.06.012
- Blum CA, Nigro N, Briel M, Schuetz P, Ullmer E, Suter-Widmer I, et al. Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 2015;385:1511-8. https://doi.org/10.1016/S0140-6736(14)62447-8
- Torres A, Sibila O, Ferrer M, Polverino E, Menendez R, Mensa J, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA 2015;313:677-86. https://doi.org/10.1001/jama.2015.88
- Martinez R, Menendez R, Reyes S, Polverino E, Cilloniz C, Martinez A, et al. Factors associated with inflammatory cytokine patterns in community-acquired pneumonia. Eur Respir J 2011;37:393-9. https://doi.org/10.1183/09031936.00040710
- Sibila O, Luna CM, Agusti C, Baquero S, Gando S, Patron JR, et al. Effects of glucocorticoids in ventilated piglets with severe pneumonia. Eur Respir J 2008;32:1037-46. https://doi.org/10.1183/09031936.00009208
- Hammerschlag MR, Chirgwin K, Roblin PM, Gelling M, Dumornay W, Mandel L, et al. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis 1992;14:178-82. https://doi.org/10.1093/clinids/14.1.178
- Chidiac C, Che D, Pires-Cronenberger S, Jarraud S, Campese C, Bissery A, et al. Factors associated with hospital mortality in community-acquired legionellosis in France. Eur Respir J 2012;39:963-70. https://doi.org/10.1183/09031936.00076911
- Williams DJ, Edwards KM, Self WH, Zhu Y, Arnold SR, McCullers JA, et al. Effectiveness of β-lactam monotherapy vs macrolide combination therapy for children hospitalized with pneumonia. JAMA Pediatr 2017; 171:1184-91. https://doi.org/10.1001/jamapediatrics.2017.3225
- Ambroggio L, Taylor JA, Tabb LP, Newschaffer CJ, Evans AA, Shah SS. Comparative effectiveness of empiric β-lactam monotherapy and β-lactam-macrolide combination therapy in children hospitalized with community-acquired pneumonia. J Pediatr 2012;161:1097-103. https://doi.org/10.1016/j.jpeds.2012.06.067
- Leyenaar JK, Shieh MS, Lagu T, Pekow PS, Lindenauer PK. Comparative effectiveness of ceftriaxone in combination with a macrolide compared with ceftriaxone alone for pediatric patients hospitalized with community-acquired pneumonia. Pediatr Infect Dis J 2014;33:387-92. https://doi.org/10.1097/INF.0000000000000119
- Bandell RA, Dekkers T, Semmekrot BA, de Wildt SN, Fleuren HW, Warlevan Herwaarden MF, et al. Macrolide prescription in Dutch children: compliance with guidelines. Eur J Clin Microbiol Infect Dis 2019;38:675-81. https://doi.org/10.1007/s10096-019-03473-7
- Mathur S, Fuchs A, Bielicki J, Van Den Anker J, Sharland M. Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review. Paediatr Int Child Health 2018;38(sup1):S66-75. https://doi.org/10.1080/20469047.2017.1409455
- Uehara S, Sunakawa K, Eguchi H, Ouchi K, Okada K, Kurosaki T, et al. Japanese guidelines for the management of respiratory infectious diseases in children 2007 with focus on pneumonia. Pediatr Int 2011;53:264-76. https://doi.org/10.1111/j.1442-200X.2010.03316.x
Cited by
- Mycoplasma pneumoniae: Atypical Pathogen in Community Acquired Pneumonia vol.14, pp.4, 2020, https://doi.org/10.22207/jpam.14.4.04